Archive: 20/03/2013

Novel Amgen virus-vaccine shrinks melanoma tumors

Shares of drugmaker Amgen Inc. are rising on news its innovative melanoma drug, which uses a virus as a Trojan horse to infiltrate and destroy tumors, shrank far more tumors than a standard treatment in a late-stage test.

Malaria vaccine fails to work after four years

A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.

page 2 from 8